Moleculin today announced the release of its Soft Tissue Sarcoma (STS) Lung Mets KOL Webcast discussing the final data from its U.S. Phase 1B/2 clinical trial evaluating Annamycin as monotherapy for the treatment of soft tissue sarcoma lung metastases (MB-107). Watch the full webcast here: https://bit.ly/3ZdPEB9 | Moleculin Biotech - MBRX | Facebook

"Sarcoma is a very tough diagnosis. It requires a huge dedication on the part of the patients to go through the treatment regimens that we lay out for them. And being a part of that team with the patient, as well as the other medical providers on the team, is just a wonderful privilege that I do not take for granted and hopefully never will." July is Sarcoma Awareness Month. Dr. John Groundland talked to us about what sarcoma is, treatment options, and the multidisciplinary team we have at HCI t